Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Brenner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Investigative Dermatology|March 27, 2022
A Commotion in the Skin: Developing Melanoma ImmunotherapiesEllen Brenner, Martin Röcken
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 30, 2015
Immunotherapy of melanoma: efficacy and mode of actionThomas Wieder, Ellen Brenner, Heidi Braumüller, et al.
The Journal of Allergy and Clinical Immunology|March 30, 2018
Immune checkpoint blockade therapyThomas Wieder, Thomas Eigentler, Ellen Brenner, et al.
Cancer Metastasis Reviews|April 10, 2017
Cytokine-induced senescence for cancer surveillanceThomas Wieder, Ellen Brenner, Heidi Braumüller, et al.
Cell Cycle (Georgetown, Tex.)|September 10, 2013
Changing T-cell enigma: cancer killing or cancer control?Thomas Wieder, Heidi Braumüller, Ellen Brenner, et al.
Cells|May 14, 2022
IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in MelanomaLorenzo Homann, Maximilian Rentschler, Ellen Brenner, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 27, 2018
Nuclear Translocation of Argonaute 2 in Cytokine-Induced SenescenceMaximilian Rentschler, Yan Chen, Jana Pahl, et al.
Journal for Immunotherapy of Cancer|January 14, 2021
Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescenceFatima Ahmetlic, Josia Fauser, Tanja Riedel, et al.
Nature|February 5, 2013
T-helper-1-cell cytokines drive cancer into senescenceHeidi Braumüller, Thomas Wieder, Ellen Brenner, et al.
Nature Communications|March 14, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursEllen Brenner, Barbara F Schörg, Fatima Ahmetlić, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Investigative Dermatology|March 27, 2022
A Commotion in the Skin: Developing Melanoma ImmunotherapiesEllen Brenner, Martin Röcken
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 30, 2015
Immunotherapy of melanoma: efficacy and mode of actionThomas Wieder, Ellen Brenner, Heidi Braumüller, et al.
The Journal of Allergy and Clinical Immunology|March 30, 2018
Immune checkpoint blockade therapyThomas Wieder, Thomas Eigentler, Ellen Brenner, et al.
Cancer Metastasis Reviews|April 10, 2017
Cytokine-induced senescence for cancer surveillanceThomas Wieder, Ellen Brenner, Heidi Braumüller, et al.
Cell Cycle (Georgetown, Tex.)|September 10, 2013
Changing T-cell enigma: cancer killing or cancer control?Thomas Wieder, Heidi Braumüller, Ellen Brenner, et al.
Cells|May 14, 2022
IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in MelanomaLorenzo Homann, Maximilian Rentschler, Ellen Brenner, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 27, 2018
Nuclear Translocation of Argonaute 2 in Cytokine-Induced SenescenceMaximilian Rentschler, Yan Chen, Jana Pahl, et al.
Journal for Immunotherapy of Cancer|January 14, 2021
Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescenceFatima Ahmetlic, Josia Fauser, Tanja Riedel, et al.
Nature|February 5, 2013
T-helper-1-cell cytokines drive cancer into senescenceHeidi Braumüller, Thomas Wieder, Ellen Brenner, et al.
Nature Communications|March 14, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursEllen Brenner, Barbara F Schörg, Fatima Ahmetlić, et al.
Pageof 1